TBPN

← Full issue

September 24, 2026

Space biotech is seen as a distinct industry in a competitive space economy

Space activity is expected to develop into multiple industries, rather than remain a field dominated solely by NASA and SpaceX. NASA is described as currently the best at human spaceflight, though it has competitors; SpaceX is said to be far ahead in launch capabilities, with Relativity and others also competing.

Space biotechnology is described as a separate segment with substantial early opportunities. The expectation is that it may eventually have many competing companies, relying on other organizations for infrastructure, launch services and human spaceflight.

Privacy ·